Potassium Citrate 10 mmol
Natural health product licensed in Canada
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 80026350
- Status
- Inactive licence
- Licence date
- 13 July 2011
- Revision date
- 9 May 2018
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- TPD Cat IV/LS
If this product were sold in France
- Dose déclarée au-delà d'une limite
Potassium: up to 2,307 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Potassium Source : Citrate de potassium Potency : 10 mEq | 384.5 mg | 2,307,000 µg |
Non-medicinal ingredients
Dioxyde de silicium colloïdal, Huile végétale hydrogénée, Triacétine, Méthylcellulose, Ethyl cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 4 Comprimé | 1 Tous les jours |
| Adultes | Not specified | minimum: 4 Comprimé ; maximum: 6 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Supplément de potassium. Pour le traitement ou la prévention de l'hypokaliémie non attribuable à une carence alimentaire.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
À ne consommer que sur l'avis d'un médecin. Les médecins et pharmaciens peuvent obtenir de la documentation professionnelle sur demande. Ne pas mastiquer, sucer ou écraser les comprimés. Il existe un lien probable entre l'emploi de comprimés enrobés contenant des sels de potassium avec ou sans diurétiques de thiazide de l'incidence de l'ulcération grave de l'intestin grêle. Ces préparations ne sont à utiliser que s'il n'est pas possible de suppléer convenablement au régime alimentaire. Il faut cesser l'emploi des qu'apparaissent des douleurs abdominales, une distension abdominales, des nausées, des vomissements ou des hémorragies gastro-intestinales.
Source
Official Health Canada record, licence 80026350
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging